Source: Eur Respir J 2010; 36: 1337-1345
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
van der Windt G.J.W., Hoogerwerf J.J., de Vos A.F., Florquin S., van der Poll T.. Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia. Eur Respir J 2010; 36: 1337-1345

Member's Comments

No comment yet.

Related content which might interest you: The lectin-like domain of thrombomodulin hampers host defence in pneumococcal pneumonia Source: Eur Respir J 2013; 41: 935-942 Year: 2013 Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections Year: 2008 IL-17RE/IL-17C mediate the recruitment of neutrophils during acute Streptococcus pneumoniae pneumonia Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Coinfection of chlamydia pneumoniae and haemophilus influenzae enhances interleukin-8 (IL-8) production in human macrophages and alveolar epithelial cells Source: Eur Respir J 2007; 30: Suppl. 51, 405s Year: 2007 TLR9- and Src-dependent expression of Krueppel-like factor 4 controls interleukin-10 expression in pneumonia Source: Eur Respir J 2013; 41: 384-391 Year: 2013 Chronic bronchial infection/colonisation: aetiology and mechanisms Source: Eur Respir Monogr 2013; 60: 34-45 Year: 2013 Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response Source: Eur Respir J 2007; 30: 1167-1172 Year: 2007 Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Source: Eur Respir J 2001; 17: 241-245 Year: 2001 The impact of time on the systemic inflammatory response in pneumococcal pneumonia Source: Eur Respir J 2010; 35: 614-618 Year: 2010 Streptococcus pneumoniae inhibits Pseudomonas aeruginosa growth on nasal human epithelium in vitro Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018 Pulmonary disease as a risk factor for community-acquired pneumonia caused by multiple pathogens, including Streptococcus pneumoniae Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001 Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissue Source: Eur Respir J 2012; 40: 1458-1467 Year: 2012 Streptococcus pneumoniae leads to secretion of VEGF by macrophages and affects angiogenesis processes Source: Eur Respir J 2006; 28: Suppl. 50, 577s Year: 2006 Molecular mechanisms and virulence of colistin-resistant klebsiella pneumoniae Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Defective macrophage phagocytosis of bacteria in COPD Source: Eur Respir J 2010; 35: 1039-1047 Year: 2010 Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 The role of ceramide in the host defense against pseudomonas aeruginosa infection Source: Eur Respir J 2006; 28: Suppl. 50, 486s Year: 2006 Infection pattern and inflammatory response in acute and persistent nontypeable haemophilus influenzae (NTHi) infection of COPD lung tissue Source: Eur Respir J 2006; 28: Suppl. 50, 841s Year: 2006